Vsee Health, Inc. VSEE

FY2025 · ended Dec 31, 2025 · Revenue $14.62M, +40.3% YoY · Filed Mar 31, 2026

Vsee Health, Inc. (VSEE) files with the SEC under industry code 8000, Services-Health Services. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $14.6 million and a net loss of $14.7 million. Free cash flow was -$3.5 million. As of Jun 30, 2026 it held $1.2 million in cash and investments and $2.0 million in total debt.

Revenue (TTM)
$15.81M
+69.2% vs year-ago TTM
Net income (TTM)
$-13.51M
+78.4% vs year-ago TTM
Operating cash flow (TTM)
$-6.31M
-59.2% vs year-ago TTM
Free cash flow (TTM)
$-6.44M
-62.1% vs year-ago TTM
EPS (TTM)
$-0.36
+90.9% vs year-ago TTM
Dividend per share
None
Shares outstanding
47.30M
+188.0% vs prior year
Net cash
$-827,216
as of Jun 30, 2026
Operating margin
-68.6%
FY 2026

Company profile

Industry
Services-Health Services (SIC 8000)
Listed as
VSEE (OTC), VSEED (OTC), VSEEW (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Boca Raton, FL
SEC filer status
Non-accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK
1864531
Former names
DIGITAL HEALTH ACQUISITION CORP. (until Jun 12, 2024)

Other Services-Health Services companies

Key figures

Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.

Line
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
Revenue
$14.6M
$10.4M
—
—
Operating income
-$9.6M
-$62.2M
-$1.9M
-$3.6M
Net income
-$14.7M
-$57.7M
-$3.8M
-$3.2M
Diluted EPS
-$0.73
-$5.65
-$0.38
-$0.25
Operating cash flow
-$3.4M
-$5.8M
-$632,595
-$1.4M
Free cash flow
-$3.5M
-$5.8M
—
—
Total assets
$22.4M
$20.0M
$805,791
$7.6M
Total liabilities
$17.0M
$20.0M
$5.1M
$7.7M
Stockholders' equity
$5.5M
-$18,488
—
—
Cash and investments
$5.3M
$326,115
$118,734
$106,998
Total debt
$2.9M
$2.6M
—
—

Recent SEC filings

Recent SEC filings
Form Description Filed Period
8-K Current report
Material agreement, New debt, Unregistered share sale
Sep 30, 2026 Sep 24, 2026
8-K Current report
Bylaw or fiscal year change
Sep 23, 2026 Sep 22, 2026
8-K Current report
Material agreement, Unregistered share sale
Sep 9, 2026 Sep 2, 2026
8-K Current report
Officer or director change
Aug 31, 2026 Aug 27, 2026
8-K Current report
Shareholder vote results
Aug 26, 2026 Aug 25, 2026
10-Q Quarterly report Aug 14, 2026 Jun 30, 2026

Source: SEC EDGAR filings. This is company-reported data, not investment advice.